Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Single-Center, Single-Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) to Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions
Conditions
Interventions
Advil Tablet (Mini) (Test Product)
Advil Tablet (Reference Product)
Locations
1
United States
Novum Pharmaceutical Research Services
Las Vegas, Nevada, United States
Start Date
December 17, 2025
Primary Completion Date
February 3, 2026
Completion Date
February 3, 2026
Last Updated
March 13, 2026
NCT07063173
NCT07046975
NCT06969963
NCT06924190
NCT06882681
NCT06830954
Lead Sponsor
HALEON
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions